Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;10(11):1593-1595.
doi: 10.1001/jamaoncol.2024.4342.

Mismatch Repair and Microsatellite Testing for Individuals With Colorectal Cancer

Totadri Dhimal  1 , Fernando Colugnati  1   2 , Bailey K Hilty Chu  1 , Anthony Loria  1 , Paula Cupertino  1 , Daniel Mulkerin  3 , Fergal J Fleming  1
Affiliations

Mismatch Repair and Microsatellite Testing for Individuals With Colorectal Cancer

Totadri Dhimal et al. JAMA Oncol. .
No abstract available

Plain language summary

This cohort study examines the institution-level and patient-level factors associated with mismatch repair and microsatellite testing for individuals with colorectal cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fleming reported receiving author royalties from UpToDate outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. National Trends in Mismatch Repair (MMR) and Microsatellite Instability (MSI) Testing Overall and by Cancer Stage
Figure 2.
Figure 2.. Associations of Facility-Level and Patient-Level Variables With Mismatch Repair (MMR) and Microsatellite Instability (MSI) Testing, 2018-2021
A, The probability of MMR/MSI testing is depicted for Community Cancer Programs (CCPs), comprehensive CCPs, academic/research programs (including National Cancer Institute–designated centers), and Integrated Cancer Programs (ICPs). Larger error bars for certain hospitals, indicating standard errors, reflect lower patient volumes at that specific center. NCCN indicates the National Comprehensive Cancer Network. B, Adjusted odds ratios (AORs) with 95% CIs are depicted for patient factors associated with MMR/MSI testing in the mixed-effect model.
See this image and copyright information in PMC

References

    1. Benson AB III, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(3):370-398. doi: 10.6004/jnccn.2017.0036 - DOI - PubMed
    1. Papke DJ, Lindeman NI, Schrag D, Iorgulescu JB. Underutilization of guideline-recommended mismatch repair/microsatellite instability biomarker testing in advanced colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(9):1746-1751. doi: 10.1158/1055-9965.EPI-22-0279 - DOI - PMC - PubMed
    1. Zhang X, Wu T, Cai X, et al. Neoadjuvant immunotherapy for MSI-H/dMMR locally advanced colorectal cancer: new strategies and unveiled opportunities. Front Immunol. 2022;13:795972. doi: 10.3389/fimmu.2022.795972 - DOI - PMC - PubMed
    1. Eriksson J, Amonkar M, Al-Jassar G, et al. Mismatch repair/microsatellite instability testing practices among US physicians treating patients with advanced/metastatic colorectal cancer. J Clin Med. 2019;8(4):558. doi: 10.3390/jcm8040558 - DOI - PMC - PubMed
    1. Beamer LC, Grant ML, Espenschied CR, et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol. 2012;30(10):1058-1063. doi: 10.1200/JCO.2011.38.4719 - DOI - PMC - PubMed